What happens when a pharmacy becomes insolvent?

rajkamalbhatti

Oct 1

7 min read

That depends on which process the company enters, and they are not interchangeable. Administration is the one designed to keep a pharmacy trading while a rescue or a sale is found. Liquidation cannot keep the doors open at all: realising the assets is the point of it. A company voluntary arrangement leaves the directors in charge and changes what the company owes. And no insolvency process is by itself a ground for taking a pharmacy off the NHS pharmaceutical list - removal runs through a separate route, and the integrated care board decides. Owners and buyers use "going into administration" to mean closing. It is closer to the opposite.

What does it mean to say a pharmacy company is insolvent?

Insolvency is a state, not a step anybody takes. Section 123 of the Insolvency Act 1986 deems a company unable to pay its debts, for the purposes of a winding-up petition under section 122(1)(f), on an unpaid statutory demand, an execution on a judgment returned unsatisfied, proof to the court that debts cannot be paid as they fall due, or liabilities exceeding assets.

A pharmacy arrives there in its own way: NHS reimbursement runs behind the month the dispensing was done, so a pharmacy can be profitable on paper and short of cash in the same week. But being insolvent is not the same as being in an insolvency process. One is a financial position, the other a formal appointment with a date, an office-holder and a statutory purpose.

What are the five processes, and which is which?

Five appear in the paperwork an owner is most likely to be handed. Only a licensed insolvency practitioner may take any of these appointments, under sections 388 to 390A of the Insolvency Act 1986.

Administration. A licensed practitioner takes day-to-day control under Schedule B1 to the Insolvency Act 1986. Paragraph 3 sets the purpose in order: rescue the company as a going concern, failing that a better result for creditors as a whole than a winding up, failing that a realisation for the secured and preferential creditors.
A company voluntary arrangement. A proposal under Part I of the same Act binding creditors to a payment arrangement, directors left in place. Creditors approve it on the majorities in rule 15.34(3) and (4) of the Insolvency (England and Wales) Rules 2016: three-quarters or more in value of those responding, failing if more than half in value of unconnected creditors vote against.
Creditors' voluntary liquidation. It starts with a members' resolution under section 84. A liquidator realises the assets and distributes them, and the company is dissolved at the end of it.
Compulsory winding up. The court orders it on a petition, under sections 122 and 124.
Administrative receivership. Effectively historic: section 72A prohibits the appointment where the qualifying floating charge was created on or after 15 September 2003, and the narrow exceptions in sections 72B to 72GA are ones a community pharmacy will not meet.

A sole trader or partnership in England and Wales sits outside all five: personal insolvency is bankruptcy.

Which of them lets a pharmacy keep dispensing?

Administration is built for it: that is what paragraph 3 means by rescuing the company as a going concern. A company voluntary arrangement does not stop the pharmacy trading either, because nothing takes the business out of the directors' hands. Liquidation is not a trading process at all.

Administration permits trading; it does not promise it. An administrator's duty is owed to the creditors as a whole, and NHS England's Pharmacy Manual (Chapter 38, paragraph 69) records that administrators have no duty to act in the interests of patients or the NHS.

A presented winding-up petition narrows everything again: once an order is made, dispositions of the company's property after presentation are void unless the court orders otherwise, under sections 127 and 129. In practice the constraint arrives well before the hearing, when the bank decides what to do with the account.

Who appoints an insolvency practitioner, and who decides?

Different people in each, and it is worth establishing which before anything else, because the answer decides what is still available. An administrator is appointed by the directors, by the company or by a qualifying floating charge holder out of court, or by the court on a creditor's application. A company voluntary arrangement is decided by the creditors, a compulsory winding up by the court, and a creditors' voluntary liquidation begins with the members' own resolution.

The recognised professional bodies authorise insolvency practitioners; the Insolvency Service oversees the regime. Because only a licensed practitioner may take the appointment, a view on which process to use carries a duty behind it only when it comes from one.

Does the pharmacy come off the pharmaceutical list?

Not because of the process. Entering administration does not remove a pharmacy from the pharmaceutical list, and NHS England's Pharmacy Manual (Chapter 38, paragraph 81) states there is no provision allowing it. Removal, contingent removal and suspension are a separate route under regulations 82 to 84 of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, they turn on fitness, and they carry appeal rights.

The list entry does not come with the shop: the incoming owner applies under regulation 26 to be included in place of the outgoing contractor, and the integrated care board decides. Equally, the contract is not lost the moment an administrator is appointed, and a seller who says it is has talked down the only thing worth selling. What happens to the NHS contract when a pharmacy changes hands? sets out that sequence.

Who has to be told, and when?

The duty follows the process, not the trouble. Regulation 67A of the 2013 Regulations, inserted by SI 2020/1126 and in force from 9 November 2020, requires a body corporate that enters administration to notify the commissioner on the date the appointment takes effect. There is no equivalent duty in liquidation, which the Pharmacy Manual confirms at paragraph 88, and none in bankruptcy at paragraph 85, and no power to remove on either of those grounds.

The General Pharmaceutical Council runs its own timetable. It holds the premises register and the superintendent pharmacist statement, and on a change of ownership the new owner must notify the GPhC within 28 days or the premises come off the register. Superintendent pharmacist and responsible pharmacist are separate statutory roles under the Medicines Act 1968, and each answers personally to the GPhC whatever the company's position.

What happens to the premises, the team and the controlled drugs?

These turn on which process too. Only a liquidator can disclaim an onerous lease, under section 178 of the Insolvency Act 1986, and the moratorium on legal process in paragraph 43 of Schedule B1 belongs to administration rather than to insolvency generally, so a landlord in a creditors' voluntary liquidation is not where an administration leaves one.

The team transfers. "Buying out of administration" is widely taken to mean buying without the staff. It does not: administration is not a proceeding instituted with a view to the liquidation of the assets, so regulation 8(7) of the Transfer of Undertakings (Protection of Employment) Regulations 2006 does not apply and regulations 4 and 7 do, following Key2Law (Surrey) LLP v De'Antiquis [2011] EWCA Civ 1567. What happens to the team when a pharmacy changes hands? takes the mechanics.

The controlled drugs are not inventory. Destruction of Schedule 1 to 4 drugs needs an authorised witness under the Misuse of Drugs Regulations 2001, moving stock to another legal entity is wholesale dealing and needs a licence under regulation 18 of the Human Medicines Regulations 2012, and whoever was required to keep the register still answers for it.

Who else is in the room, and who does what?

Six roles, and conflating any two of them leaves part of the work undone. Only the licensed insolvency practitioner can take an appointment. The solicitor does the documents and the lease; the accountant takes the numbers and every tax question, theirs alone; the lender decides whether facilities continue; the integrated care board decides the list entry; and the GPhC the premises registration.

RSB Consulting is none of those. Not an insolvency practitioner, not a solicitor, not an accountant, not a lender, and it does not hold itself out as any of them. It works on the pharmacy side alongside them: whether the branch can keep dispensing, and what a buyer is taking on. That is the work set out on pharmacy insolvency and distressed sales, with the other roles brought in through the adviser network.

What should I do with all of this?

Establish three facts first: which process, who appointed, and on what date. Almost every question that follows turns on those three. This post carries no to-do list, because there is already one: A distressed pharmacy: what to do in the first fortnight sets out the order to work in.

What to do next

Start by establishing which process you are actually in, and whether anything has been filed. The five routes are not interchangeable, and the options still open to you narrow sharply once an appointment is made. If a notice of intention has been filed, the clock has already started.

You will need a licensed insolvency practitioner, because only a licensed practitioner may take an appointment, and a solicitor for the lease and the contracts. Your accountant takes the tax. RSB does not do that work and would not pretend to.

What RSB does is the part nobody else covers: reading what the pharmacy is actually worth to a buyer in that condition, what the NHS contract does next, and which of those advisers you need first. Come here before you appoint anyone, because the order you do things in changes what you are left with. Tell us where you are, in confidence, and you will get a straight view of it — including if the answer is that you need someone else.

If you want the detail on how distressed pharmacy sales run, that is on the pharmacy insolvency page, and the advisers are on the network.

General information as at 1 October 2026, not legal, financial, insolvency or tax advice, and no conclusion about your company. The lens is England: the pharmaceutical list, the integrated care board and regulation 26 are English. Wales runs the National Health Service (Pharmaceutical Services) (Wales) Regulations 2020 and its seven Local Health Boards, Scotland SSI 2009/183 and its territorial NHS boards, and Northern Ireland is out of scope with its own regulator. A licensed insolvency practitioner and a solicitor confirm the legal points; your accountant takes the tax. If you are not sure which process you are in, tell us where you are.

Rajkamal Singh Bhatti MPharm is a practising pharmacist (GPhC registration 2230365) and a former Superintendent Pharmacist of a national group of 120 branches, which he took through insolvency and sale. He founded RSB Consulting.